Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-00-015928
Filing Date
2000-04-03
Accepted
2000-04-03 00:00:00
Documents
9
Period of Report
2000-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 273641
2 EXHIBIT 10.7.3 EX-10.7-3 11110
3 EXHIBIT 10.28.4 EX-10.28-4 60234
4 EXHIBIT 10.28.5 EX-10.28-5 32608
5 EXHIBIT 10.32.2 EX-10.32-2 14726
6 EXHIBIT 10.51.4 EX-10.51-4 15348
7 EXHIBIT 23.1 EX-23.1 1201
8 EXHIBIT 27 EX-27 1992
9 EXHIBIT 99 EX-99 26737
  Complete submission text file 0000912057-00-015928.txt   439729
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GENZYME TRANSGENICS CORP (Filer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0103
Type: 10-K | Act: 34 | File No.: 000-21794 | Film No.: 592802
SIC: 2836 Biological Products, (No Diagnostic Substances)